Structure Therapeutics Inc. — Director's Dealing 2023

Feb 3, 2023

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Structure Therapeutics Inc. (GPCR)
CIK: 0001888886
Period of Report: 2023-02-02

Reporting Person: FIL Ltd (10% Owner, See Remark 1)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Series A Convertible Preferred Shares	$		Ordinary Shares (4013678)		Indirect
Series A+ Convertible Preferred Shares	$		Ordinary Shares (620499)		Indirect
Series B Convertible Preferred Shares	$		Ordinary Shares (452867)		Indirect
Series B-1 Convertible Preferred Shares	$		Ordinary Shares (179242)		Indirect
Series A Convertible Preferred Shares	$		Ordinary Shares (71636)		Indirect
Seriers A+ Convertible Preferred Shares	$		Ordinary Shares (10154)		Indirect
Series B Convertible Preferred Shares	$		Ordinary Shares (7411)		Indirect
Series B-1 Convertible Preferred Shares	$		Ordinary Shares (494035)		Indirect
Series A Convertible Preferred Shares	$		Ordinary Shares (624239)		Indirect

Footnotes

F1: The Series A+, A, B, and B-1 preferred shares are convertible on a 1-for-1 basis into the number of shares of Ordinary Shares as shown in column 3 at any time at the holder's election, and automatically upon the closing of the Issuer's initial public offering without payment or further consideration, and have no expiration date.